Works matching IS 2574173X AND DT 2020 AND VI 40 AND IP 2

Results: 14

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 201, doi. 10.1002/npr2.12110

By:

Sasayama, Daimei;
Hattori, Kotaro;
Yokota, Yuuki;
Matsumura, Ryo;
Teraishi, Toshiya;
Yoshida, Sumiko;
Kunugi, Hiroshi

Publication type:

Article

Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic‐like effects without affecting cognitive enhancement and cataleptic effects in rats.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 190, doi. 10.1002/npr2.12108

By:

Arakawa, Keita;
Maehara, Shunsuke

Publication type:

Article

Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication).

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 122, doi. 10.1002/npr2.12107

By:

Ishigooka, Jun;
Usami, Tomohiro;
Iwashita, Shuichi;
Kojima, Yoshitsugu;
Matsuo, Satoshi

Publication type:

Article

Discrepancies in Wechsler Adult Intelligent Scale III profile in adult with and without attention‐deficit hyperactivity disorder.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 166, doi. 10.1002/npr2.12106

By:

Takeda, Toshinobu;
Nakashima, Youta;
Tsuji, Yui

Publication type:

Article

Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM‐878.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 182, doi. 10.1002/npr2.12105

By:

Maehara, Shunsuke;
Yuge, Natsuko;
Higashi, Chika;
Ota, Takumi;
Furukawa, Junji;
Takeuchi, Takashi

Publication type:

Article

Apathy symptoms induced by low‐dose venlafaxine: Two cases.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 196, doi. 10.1002/npr2.12104

By:

Sato, Shinji;
Sodeyama, Noriko;
Matsuzaki, Asaki;
Shiratori, Yuki

Publication type:

Article

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 138, doi. 10.1002/npr2.12103

By:

Ogyu, Kamiyu;
Noda, Yoshihiro;
Yoshida, Kazunari;
Kurose, Shin;
Masuda, Fumi;
Mimura, Yu;
Nishida, Hana;
Plitman, Eric;
Tarumi, Ryosuke;
Tsugawa, Sakiko;
Wada, Masataka;
Miyazaki, Takahiro;
Uchida, Hiroyuki;
Graff‐Guerrero, Ariel;
Mimura, Masaru;
Nakajima, Shinichiro

Publication type:

Article

Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorder.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 175, doi. 10.1002/npr2.12102

By:

Omileke, Favour;
Ishiwata, Sayuri;
Matsuo, Junko;
Yoshida, Fuyuko;
Hidese, Shinsuke;
Hattori, Kotaro;
Kunugi, Hiroshi

Publication type:

Article

Time estimation in a case of Tourette's syndrome: Effect of antipsychotic medications.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 198, doi. 10.1002/npr2.12101

By:

Inagawa, Takuma;
Ueda, Natsuki;
Nakagome, Kazuyuki;
Sumiyoshi, Tomiki

Publication type:

Article

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 130, doi. 10.1002/npr2.12100

By:

Yamasaki, Katsuhiko;
Hasegawa, Tomonori;
Takeda, Masatoshi

Publication type:

Article

Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 157, doi. 10.1002/npr2.12099

By:

Kajitani, Naofumi;
Iwata, Masaaki;
Miura, Akihiko;
Tsunetomi, Kyohei;
Yamanashi, Takehiko;
Matsuo, Ryoichi;
Nishiguchi, Tsuyoshi;
Fukuda, Saki;
Nagata, Mayu;
Shibushita, Midori;
Yamauchi, Takahira;
Pu, Shenghong;
Shirayama, Yukihiko;
Watanabe, Ken;
Kaneko, Koichi

Publication type:

Article

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 150, doi. 10.1002/npr2.12098

By:

Kudo, Noriko;
Yamamori, Hidenaga;
Ishima, Tamaki;
Nemoto, Kiyotaka;
Yasuda, Yuka;
Fujimoto, Michiko;
Azechi, Hirotsugu;
Niitsu, Tomihisa;
Numata, Shusuke;
Ikeda, Manabu;
Iyo, Masaomi;
Ohmori, Tetsuro;
Fukunaga, Masaki;
Watanabe, Yoshiyuki;
Hashimoto, Kenji;
Hashimoto, Ryota

Publication type:

Article

PET technology for drug development in psychiatry.

Published in:

Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 114, doi. 10.1002/npr2.12084

By:

Arakawa, Ryosuke;
Takano, Akihiro;
Halldin, Christer

Publication type:

Article

Issue Information.

Published in:: Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 113, doi. 10.1002/npr2.12062
Publication type:: Article